RxDoctor Payments Data

Linda Hunter

Nurse Practitioner · Richland, MSNPI 1376555045

Payments from drug & device makers

$1,768in general payments, 2019–2025

Across 59 payments — averaging $29.96 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novo Nordisk$338
  • Amgen$256
  • GSK$236
  • AbbVie$145
  • AstraZeneca$132
  • Inspire Medical Systems, Inc.$128
  • plus $531 from 11 others

What the payments were for

  • Food & beverage$1,768100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$1,768 in reported general payments places this provider in the 80th percentile of 1,090 nurse practitioner providers in Mississippi.

See all nurse practitioner providers in Mississippi

Medicare billing

Part B allowed, 2024
$53,025
Medicare patients
159
Services billed
3,105

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
AbrysvoRsv Vacc, Pref A And Pref B/Pf138$40,626
RybelsusSemaglutide29$31,536
OzempicSemaglutide17$30,659
ShingrixVaricella-Zoster Ge/As01b/Pf95$19,554
EliquisApixaban16$17,124
Trelegy ElliptaFluticasone/Umeclidin/Vilanter13$16,941
Diclofenac Sodium89$1,824
Rosuvastatin Calcium75$1,093
Omeprazole69$1,041
Gabapentin67$970
Oxybutynin Chloride18$962
Ezetimibe38$931
Boostrix TdapDiphth,pertuss(Acell),tet Vac13$828
Levothyroxine Sodium83$715
Albuterol Sulfate HfaAlbuterol Sulfate21$688

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskRybelsus, Ozempic$338$62,19546 claims
GSKShingrix, Trelegy Ellipta$236$36,496108 claims
AbbVieSynthroid$145$35420 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 1,090 nurse practitioner providers in Mississippi.

Other nurse practitioner in Richland

See the full list for Mississippi

Where these figures come from

Is this you, or does something look wrong? →